PASG: Passage Bio, Inc. Stock

by  •  • Comments Off on PASG: Passage Bio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 75.17
Enterprise Value ($M) 53.46
Book Value ($M) 111.28
Book Value / Share 1.81
Price / Book 0.68
NCAV ($M) 78.70
NCAV / Share 1.28
Price / NCAV 0.96

Profitability (mra)
Return on Invested Capital (ROIC) -0.74
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.60

Liquidity (mrq)
Quick Ratio 7.22
Current Ratio 7.22

Balance Sheet (mrq) ($M)
Current Assets 117.96
Assets 150.54
Liabilities 39.26
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -103.00
Net Income -102.06

Cash Flow Statement (mra) ($M)
Cash From Operations -78.26
Cash from Investing 65.24
Cash from Financing 0.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-12 13D/A Orbimed Advisors Llc 13.00 0.00
03-29 13G Lynx1 Capital Management LP 8.70 1,178.06
11-09 13D/A Versant Venture Capital VI, L.P. 7.30 0.00
06-15 13D/A Frazier Life Sciences IX, L.P. 4.70 -32.29

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-04 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-13 10-Q Y UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-07 10-Q Y UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-11 10-Q Y UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 15,755 15,661 100.60
2024-04-25 373 1,435 25.99
2024-04-24 5,208 7,110 73.25

(click for more detail)

Similar Companies
OPTN – OptiNose, Inc. ORIC – ORIC Pharmaceuticals, Inc.
OVID – Ovid Therapeutics Inc. PBYI – Puma Biotechnology, Inc.
PCRX – Pacira BioSciences, Inc.


Financial data and stock pages provided by
Fintel.io